Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morning vs Evening Antihypertensive Drug Administration on Albuminuria in Hypertensive Patients (MORE trial)
TCTR20240930002Phase 2Completed
- Sponsor
- Navamindradhiraj University
- Start
- Mar 2021
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in hypertension (HTN) (2 arms), sponsored by Navamindradhiraj University. Started Mar 2021; status: completed.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20240930002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240930002.